StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
Shares of AEZS opened at $1.95 on Friday. Aeterna Zentaris has a 52 week low of $1.36 and a 52 week high of $3.38. The stock has a market capitalization of $9.48 million, a price-to-earnings ratio of -0.57 and a beta of 1.57. The stock has a fifty day moving average of $1.95 and a 200-day moving average of $1.90.
About Aeterna Zentaris
See Also
- Five stocks we like better than Aeterna Zentaris
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The Charles Schwab Company Can Hit New Highs
- How to Read Stock Charts for Beginners
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- CD Calculator: Certificate of Deposit Calculator
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.